Nanwei Medical disclosed its semi-annual report on August 26. In the first half of 2026, the company achieved operating revenue of 1.728 billion yuan, up 10.39% year on year, but net profit attributable to shareholders of the listed company was 303 million yuan, down 16.5% year on year, with basic earnings per share of 1.63 yuan. The company plans to distribute a cash dividend of 5.0 yuan, tax included, for every 10 shares. During the reporting period, the company had a relatively high exposure to foreign currency funds and foreign currency monetary assets. Affected by the appreciation of the renminbi, the translation of foreign currency asset exposure resulted in an exchange loss of 83 million yuan, which had a short-term negative impact on first-half profit.
Micro Tech Nanjing Co LtdNet profit fell 16.5% due to exchange losses from RMB appreciation, though revenue grew and dividend planned.
